A new therapy for transthyretin amyloidosis, no longer an orphan condition.

European Heart Journal Supplements : Journal of the European Society of Cardiology
Candida Cristina QuartaClaudio Rapezzi

Abstract

Amyloid cardiomyopathy is a condition characterized by intra-myocardial deposit of protein-like material, in fibrillar shape (amyloid), which presence determine a progressive thickening and stiffening of the cardiac walls leading to a cardiac dysfunction. The proteins most often involved with cardiac amyloid are the light chains of the immunoglobulin, typical of amyloidosis AL, and transthyretin, responsible for transthyretin amyloidosis, in both its forms, hereditary and wild type. An accurate estimate of the incidence of cardiac amyloidosis is still difficult due to the variety and complexity of the clinical presentation of the condition. Nonetheless, the condition has stimulated the interest of the scientific community, so that a specific diagnostic path has been developed, beginning from the clinical suspicion and first-line testing, such as electrocardiogram, echocardiogram, and blood work, to progress to the diagnostic confirmation using more sophisticated testing such as magnetic resonance, scintiscan, and eventually cardiac biopsy. To understand and recognize this condition is very important, stemming from the availability of 'aetiology oriented therapies' (designed to prevent, control and possibly regress amyloid depos...Continue Reading

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P WestermarkG G Cornwell
Jan 5, 2005·Circulation·Alicia Maria MaceiraDudley John Pennell
Sep 28, 2005·Circulation·Rodney H Falk
Feb 5, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Arnt V KristenAlexander Bauer
Feb 8, 2008·The New England Journal of Medicine·Roy Freeman
May 19, 2010·Nature Reviews. Cardiology·Claudio RapezziAngelo Branzi
Mar 10, 2012·Annals of Clinical Biochemistry·Jennifer H Pinney, Philip N Hawkins
Aug 14, 2012·Heart·Jason N DunguPhilip N Hawkins
Dec 19, 2012·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Zarina GioevaChristoph Röcken
Dec 26, 2013·JAMA : the Journal of the American Medical Association·John L BerkUNKNOWN Diflunisal Trial Consortium
Sep 30, 2014·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Jean D SipePer Westermark
Mar 12, 2015·Heart Failure Reviews·Claudio RapezziMathew S Maurer
May 5, 2016·Circulation·Julian D GillmorePhilip N Hawkins
Aug 28, 2018·The New England Journal of Medicine·Mathew S MaurerUNKNOWN ATTR-ACT Study Investigators

❮ Previous
Next ❯

Citations

Aug 7, 2021·Mayo Clinic Proceedings·Carlo FumagalliFrancesco Cappelli

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
biopsy

Related Concepts

Related Feeds

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.